FDA Grants Therapy Designation to Idorsia
The FDA granted a therapy designation to Idorsia; its shares were up 1.66%.
Related stories
SunScout Holdings Receives Conditional US Approval to Operate Robotic Equipment
The US Department of War and FCC granted approval subject to compliance with onshoring plans and product vetting requirements.
M impact | REGULATION | Nov 04, 2026, 08:03 PM UTC
French Central Banker Says France Must Solve Fiscal Problems Alone
French central banker: France alone must solve fiscal problems PARIS, Nov 4 (Reuters) - France can b
L impact | REGULATION | Nov 04, 2026, 07:47 PM UTC
US Sanctions Indian and Turkish Firms and Individuals Over Iran
M impact | REGULATION | Nov 04, 2026, 07:36 PM UTC
Canada and China Agree to Extend Tariff Exemptions Through 2028
Canada and China agreed to extend tariff exemptions on several products through 2028.
M impact | REGULATION | Nov 04, 2026, 07:34 PM UTC
Exelon Files FERC Complaint Challenging PJM Capacity Auction Schedule
L impact | REGULATION | Nov 04, 2026, 07:32 PM UTC
Exelon files FERC complaint over PJM capacity auction schedule
L impact | REGULATION | Nov 04, 2026, 07:31 PM UTC